Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim A Papp

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
Dermatology and Therapy|July 6, 2023
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Jennifer Beecker, Curtis Cooper, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
Dermatology and Therapy|April 21, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Jennifer Beecker, Curtis Cooper, et al.
The New England Journal of Medicine|July 16, 2020
Trial of Roflumilast Cream for Chronic Plaque PsoriasisMark G Lebwohl, Kim A Papp, Linda Stein Gold, et al.
Dermatology and Therapy|March 17, 2023
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Barbara Melosky, Sandeep Sehdev, et al.
The Journal of Investigative Dermatology|August 16, 2025
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-RSandra Garcet, Lam C Tsoi, Hong Hur, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Archives of Dermatological Research|June 8, 2024
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registryKim A Papp, Melinda Gooderham, Charles Lynde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyKristian Reich, Jonathan I Silverberg, Kim A Papp, et al.
Journal of Cutaneous Medicine and Surgery|August 12, 2023
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
Dermatology and Therapy|July 6, 2023
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Jennifer Beecker, Curtis Cooper, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
Dermatology and Therapy|April 21, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Jennifer Beecker, Curtis Cooper, et al.
The New England Journal of Medicine|July 16, 2020
Trial of Roflumilast Cream for Chronic Plaque PsoriasisMark G Lebwohl, Kim A Papp, Linda Stein Gold, et al.
Dermatology and Therapy|March 17, 2023
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Barbara Melosky, Sandeep Sehdev, et al.
The Journal of Investigative Dermatology|August 16, 2025
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-RSandra Garcet, Lam C Tsoi, Hong Hur, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Archives of Dermatological Research|June 8, 2024
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registryKim A Papp, Melinda Gooderham, Charles Lynde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyKristian Reich, Jonathan I Silverberg, Kim A Papp, et al.
Journal of Cutaneous Medicine and Surgery|August 12, 2023
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, et al.
Pageof 22